The in vitro treatment of monocytes with SLE and RA serum before RTX treatment promoted increased expression of pro‐thrombotic and pro‐inflammatory molecules (TF, VEGF, MCP‐1, IL‐8, IL‐1ß). Here, CCL2 is linked to systemic lupus erythematosus.